The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores for research advancing medical knowledge that can improve human health. The program provides support for investigators in obtaining final data that: Will be used for development of a clinical/translational proposal to be submitted for extramural funding; […]
Pre-configured panels are available for next day delivery Unique targets in the market: ADAM12, PAPP-A, CD66f (PSBG-1), HO-1 (Heme Oxygenase 1), and Beta-catenin Ask me about matching ProcartaPlex panels on our RNA multiplex platform (QuantiGene) Key Features of ProcartaPlex Immunoassays: Multianalyte detection with a large dynamic range All ProcartaPlex assays are individually tested for specificity […]
Rapidly detect SARS-CoV-2 coronavirus antibodies (immunoglobulins, IgG and IgM) or viral proteins in serum or plasma ProcartaPlex Human Coronavirus Ig Total 11-Plex Panel This Human SARS-CoV-2 Spike (trimer) ELISA kit enables the detection of anti-SARS-CoV-2 Ig antibodies in human serum with great sensitivity and specificity. Human SARS-CoV-2 Protein, Serology and Neutralizing Ab ELISAs Human SARS-CoV-2 ELISA […]
Measure Ig titers We offer a comprehensive menu of Invitrogen™ ELISA and ProcartaPlex™ assays for serological detection of immunoglobulins (Ig) in response to SARS-CoV-2 infection or vaccination. Fast, easy workfl ow—incubation times of 1.5 hr for ELISAs (Fig. 1) or 2.5 hr for ProcartaPlex assays High sensitivity and specifi city—developed and validated with PCR (+) […]
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
Vaccines likely induce strong, persistent immunity to COVID-19
This episode of ‘Show Me the Science’ details how School of Medicine scientists began working with the virus, ramping up research efforts while the rest of the world was shutting down
On June 12, 2020, the IML and the Shreiber Lab participated in Wear White for a Future. By wearing white together, we are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer
A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and […]
A new School of Medicine study indicates a way for cancer immunotherapy to spur a more robust immune response. Such knowledge could lead to the development of better cancer vaccines and more effective immunotherapy drugs.